Family · Pharmaceutical analytical standards
Dicloxacillin
A beta-lactamase-resistant penicillin of the isoxazolyl penicillin family, patented in 1961 and approved for medical use in 1968: it is used mainly against staphylococcal infections of the skin and bones. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?The prefix 'di-' recalls the two chlorine atoms on the phenyl ring of its side chain; together with the isoxazolyl group, this side chain shields it from the enzymes bacteria use to destroy penicillin.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
